BSBeata Skonieczna

Beata Skonieczna

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beata Skonieczna has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NHC-Au-Xanthate Complexes: Selective Cytotoxic Activity and Mechanistic Insights

    by Katarzyna Niemirowicz-Laskowska, Marta PietruszyńsKa, Supratim Chakraborty, Piotr F. J. LipińsKi, Wioletta KośnIk, Beata Skonieczna, Iwona Misztalewska-Turkowicz, Halina Car, Michał Michalak

    In this study, a series of NHC-Au-xanthate (NHC-Au-Xa) complexes was evaluated for their antiproliferative activity and mechanism of action. Molecular docking studies identified thioredoxin reductase (TrxR) as a plausible molecular target and suggested that the inhibitory potency may depend on the ability of the complexes to position the gold center in close proximity to the catalytic selenocysteine residue. Consistent with this hypothesis, the investigated compounds induced TrxR inhibition, leading to an intracellular redox imbalance, enhanced reactive oxygen species (ROS) generation, increased release of damage-associated molecular patterns (DAMPs), including HMGB1, and activation of both apoptotic and necrotic cell death pathways. The aforementioned mechanism might indicate the engagement of immunologically relevant cell death responses. Additionally, fluorescence studies demonstrated the preferential accumulation of a representative complex in cancer cells compared with normal fibroblasts. In conclusion, these findings provide new insights into the mechanism of action of NHC-Au-xanthate complexes and highlight their potential as redox-active anticancer agents with possible chemoimmunotherapeutic relevance.

  • Open Access

    Cyclodextrin-Based Nanocarriers for 5-Fluorouracil: Cholesteryl Modification Enhances Antitumor Activity Against Colorectal Cancer Cells

    by Beata Skonieczna, Bartosz Maliszewski, Natalia Wasiluk, Halina Car, Agnieszka Z Wilczewska, Paweł Misiak, Katarzyna Niemirowicz-Laskowska

    Background: The objective of this study is to evaluate the biological activity of cholesterol-modified cyclodextrin (CD21chol) complexes with 5-fluorouracil (5-FU) prepared at different molar ratios (1:1, 1:2, and 1:3) and to identify the most potent anticancer formulation. Methods: The inclusion complexes of CD21chol:5-FU were prepared at different molar ratios (1:1, 1:2, and 1:3) and initially characterized based on their physicochemical properties, such as increased negative surface charge and particle size. Subsequently, the biological activity was investigated in the human colorectal cancer cell line DLD-1 by analyzing cell viability, metabolic activity, membrane integrity, and apoptosis (activation of caspases 3/7, 8, and 9). Cytotoxicity was also measured in non-tumorigenic fibroblasts and cardiomyocytes. Results: The complexation with 5-FU resulted in a shift toward more negative zeta potential values, with the 1:3 CD21chol:5-FU system showing the greatest change and improved physicochemical stability. Particle size analysis revealed a reduction in hydrodynamic diameter at lower drug ratios (1:1 and 1:2), followed by an increase at the 1:3 ratio. Biologically, the 1:3 complex exerted the strongest cytotoxic effect against DLD-1 cells, reducing metabolic activity and cell viability by over 60%, increasing LDH release, and significantly activating caspases 3/7, 8, and 9, indicating engagement of both intrinsic and extrinsic apoptotic pathways. In contrast, only moderate toxicity was observed in CCD-1079SK fibroblasts and H9c2(2– 1) cardiomyocytes. Conclusion: The results indicate that CD21chol-based delivery systems enhance the anticancer activity of 5-FU. The 1:3 complex appears to be the most promising candidate for further development in colorectal cancer therapy. The diagram illustrates the effects of CD21chol-5-FU nanocarriers on different cell types. Cardiomyocytes and fibroblasts are shown with arrows indicating moderate cytotoxicity. The nanocarriers are composed of β-cyclodextrin, cholesterol hemisuccinate and 5-fluorouracil. Colon cancer cells are depicted with arrows leading to reduced viability, LDH release and apoptosis, resulting in cell death. The nanocarriers are central to the process, interacting with the cells and leading to these outcomes.Diagram of CD21chol-5-FU nanocarriers affecting cardiomyocytes, fibroblasts and colon cancer cells.

  • Open Access

    Magnetic AuNPs@TiO 2 @NF heterojunction for solar-light degradation of antibiotics and mitigation of bacterial resistance risk

    by Joanna Breczko, Anna Basa, Katarzyna Niemirowicz-Laskowska, Beata Skonieczna, Raúl López-Martín, Jose A. De Toro, Halina Car, Elzbieta Regulska

    Antibiotic resistance is a silent crisis unfolding in slow motion, and sustainable solutions are urgently needed. We developed a solar-powered, magnetically recoverable Au@TiO2@NF photocatalyst that degrades 91% of tigecycline in 33 minutes and eliminates its toxicity. The material's porous SiO2-templated framework (53 m2 g−1) integrates plasmonic gold nanoparticles and magnetic nickel ferrite (NF), optimizing light absorption and recyclability. Structural analysis confirmed crystalline anatase TiO2 and cubic NF phases, while electron microscopy revealed an interconnected porous network that enhances reactivity. Radical scavenger experiments identified superoxide radicals (˙O2 −) are the primary active species, with photogenerated holes and hydroxyl radicals (˙OH) playing complementary roles. This synergistic action is enhanced by our material's design: plasmonic gold injects hot electrons, while the tailored interface between TiO2 and NF promotes efficient charge separation, yielding a 3.6-fold efficiency gain over TiO2 alone. The catalyst is stable across a broad pH range (4.5–10) and is fully recovered post-reaction using a magnet, preventing secondary nanoparticle pollution. Degradation byproducts show no cytotoxicity in human fibroblasts, monocytes, or hepatocytes and reduce pro-inflammatory TNF-α by 40–60%. Crucially, it preserves CYP3A4 activity, avoiding drug-interaction risks. The material also functions as an electrochemical H2O2 sensor (LOD: 0.0447 mM), demonstrating multifunctionality. This work shows promise for antibiotic wastewater treatment. The solar-driven approach is efficient and environmentally safe.